公开(公告)号：US20180228879A1

公开(公告)日：2018-08-16

申请号：US15890290

申请日：2018-02-06

Applicant: Bioverativ Therapeutics Inc.

Inventor： Glenn PIERCE ,  SAMANTHA TRUEX ,  ROBERT T. PETERS ,  HAIYAN JIANG

IPC: A61K38/48 ,  C12N9/96 ,  C07K14/76 ,  A61K39/395 ,  C07K16/18 ,  A61K9/00 ,  C12N9/64 ,  A61K38/38 ,  A61K47/64

Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.

公开(公告)号：US20180228878A1

公开(公告)日：2018-08-16

申请号：US15890284

申请日：2018-02-06

Applicant: Bioverativ Therapeutics Inc.

Inventor： GLENN PIERCE ,  SAMANTHA TRUEX ,  ROBERT T. PETERS ,  HAIYAN JIANG

IPC: A61K38/48 ,  C12N9/96 ,  C07K14/76 ,  A61K39/395 ,  C07K16/18 ,  A61K9/00 ,  C12N9/64 ,  A61K38/38 ,  A61K47/64

Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.